PatientsVille.com Logo

CARDIAC ARREST and Doxycycline

PatientsVille

CARDIAC ARREST Symptoms and Causes

The heart has an internal electrical system that controls the rhythm of the heartbeat. Problems can cause abnormal heart rhythms, called arrhythmias. There are many types of arrhythmia. During an arrhythmia, the heart can beat too fast, too slow, or it can stop beating. Sudden Cardiac arrest (SCA) occurs when the heart develops an arrhythmia that causes it to stop beating. This is different than a heart attack, where the heart usually continues to beat but blood flow to the heart is blocked.

There are many possible causes of SCA. They include coronary heart disease, physical stress, and some inherited disorders. Sometimes there is no known cause for the SCA.

Without medical attention, the person will die within a few minutes. People are less likely to die if they have early defibrillation. Defibrillation sends an electric shock to restore the heart rhythm to normal. You should give cardiopulmonary resuscitation (CPR) to a person having SCA until defibrillation can be done.

If you have had an SCA, an implantable cardiac defibrillator (ICD) reduces the chance of dying from a second SCA.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for CARDIAC ARREST

CARDIAC ARREST treatment research studies

Doxycycline clinical trials, surveys and public health registries


Find Drug Side Effect reports



Doxycycline Side Effects

Headache (176)
Nausea (172)
Rash (127)
Pain (125)
Vomiting (125)
Dyspnoea (124)
Dizziness (123)
Haemorrhage (116)
Malaise (114)
Diarrhoea (111)
Oesophageal Ulcer (98)
Pyrexia (96)
Chest Pain (95)
Fatigue (93)
Pruritus (92)
Abortion Incomplete (91)
Anxiety (90)
Photosensitivity Reaction (88)
Asthenia (82)
Abdominal Pain Upper (71)
Depression (41)
Abdominal Pain (40)
Anaemia (38)
Stevens-johnson Syndrome (35)
Suicidal Ideation (34)
Muscle Spasms (32)
Confusional State (32)
Vision Blurred (31)
Oesophagitis (31)
Oedema Peripheral (31)
Dyspepsia (30)
Hypotension (30)
Pancreatitis (30)
Syncope (30)
Benign Intracranial Hypertension (29)
Paraesthesia (28)
Palpitations (28)
Arthralgia (27)
Erythema (27)
Visual Impairment (27)
Intracranial Pressure Increased (27)
Pulmonary Embolism (27)
Dysphagia (26)
Blister (26)
Abdominal Discomfort (25)
Pancreatitis Acute (25)
Renal Failure Acute (25)
Panic Attack (25)
Hypersensitivity (24)
Swollen Tongue (24)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I have just come back from a funeral for my brother. He was just 62. He was on statin medicine but his cholestrol, blood pressure, weight and diet was very much in control. In fact just a day before his death the doctor told him that he was doing f

I am 11 days into a 20 day regime of Doxycycline for Staph. I am 51 and have not had a period in 2 years. 2 days ago I had some breast tenderness and this morning I woke to classic menstrual bleeding with abdominal cramps. Could the Doxycyclin

I am a 45 year old women who developed acne 4 years agao after my hysterectomy.Ihave been using doxycycline for the last 10 months......the only side effects I have experienced are nausea if pill tkn in empty stomach and weight gain ( which

I am anaemic and i've been treating my acne with doxycycline but instead my anaemia got worse i'm drowzy,my head feels heavy and i have a headache from hell.

I had these 100mg tablets for a sinus infection its gone now i take the last 1 tomorrow but after the few few days on them i ad to take 8 2 to start with then 1 a day. so after a few days on them i got 2 complaints my anus was a bit sore and neck an

I have just taken myself off Doxycycline. I had so much pressure in my skull - unable to stand for very long, felt really weak and thought I was going to pass out..A Few pains in my kidney area.

I took doxycycline for 10 days for perioral dermatitis. A week after completing the medicine I went to the ER with a burning in my chest. Then I lost my appetite, was nauseousand started losing weight. Three weeks later I was diagnosed with

I was taking doxycycline for an MRSA staph infection. I had tightness in my chest and worsening difficulty breathing, sore tongue, burning palms and soles of my feet, and extreme exhaustion. At the end of my 9th day on the medication, I had excruti

I was taking doxycycline for meibomitis and a little over 2 weeks after I started I came ill with severe head pressure,tinnitus,chills,nausea,flulike symptoms and after 2 emergency room visits and 6 different doctors (who were trying to treat me for

I was taking them as an anti-malarial. Caused a duodenal ulcer and a bleed on the brain, either of which could have killed me. Both nearly did, I had 3 months in hospital and 8 operations before I was discharged. I will probably never be properly wel

Dear Sir/Madam, We are 'Alispo International' from Sialkot Pakistan. As a manufacturer, we supply 'SURGICAL DENTAL HAND INSTRUMENTS' in high quality, including Gynecology, ENT, Ophthalmic, Cardiac, Orthodontic and endodontic instruments. O

<b>Describe Your Tazocin Experience Here:</b>after it was administered to my farther in hospital for the first time on day he was due to be released he had a cardiac arrest with multiple organ failure and subsequently died

<span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/lumigan-cardiac-disorder.htm' rel='nofollow'>cardiac disorder</a>, <a href='http://sideeffects101.com/drug-side-effects/lumigan-dyspnoea.htm' r

AGGRENOX SIDE EFFECT. PATIENT WAS PRESCRIBED PLAVIX. AGGRENOX WAS SUBSTITUTED. PATIENT SUFFERED ACUTE RESPIRATORY FAILURE AND CARDIO-RESPIRATORY ARREST. PATIENT WAS HOSPITALIZED. PATIENT DIED 3/29/09.

Anything to indicate tha Xeloda causes cardiac arrest or arrhythmia? I had cardiac arrest and the doctors can find no other reason.

Can itching sensation in the whole body be related to Massive Cardiac Failure? Was it a symptom of increasing cholesterol in the body?

Cardiac flutter, fatigue

Cardiac vegetation

Causes of cardiac vegetations

Hello, after xray report says normal size cardiac silhouette. bronchitic change seen both lungs. please advice

CARDIAC ARREST Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Coronary Aneurysm
Interventions: Drug: Doxycycline;   Drug: Standard care
Outcome Measures: Coronary artery diameter change;   Assess the change in MMP-9 level;   Assess a change in TIMP level
2 Unknown  Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population
Condition: Malignant Pleural Effusion
Interventions: Drug: Doxycycline;   Other: normal saline
Outcome Measures: Time to pleurodesis;   Pleurodesis rates at 90 days post Pleurx insertion;   Number of participants with adverse events;   Effects on pulmonary function
3 Unknown  Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis
Condition: Transthyretin Amyloidosis
Intervention: Drug: Doxycycline + Tauroursodeoxycholic acid
Outcome Measures: Response rate to Doxycycline + tauroursodeoxycholic acid treatment;   Number of patients experiencing treatment-emergent adverse events;   Change in quality of life;   Doxycycline pharmacokinetics (PK);   response in autonomic dysfunction, sensory-motor peripheral neuropathy and visceral organ involvement;   neurologic response;   Incidence of patients discontinuing from the study because of clinical or laboratory adverse events
4 Recruiting Doxycycline in Therapy of Erythema Migrans
Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
Outcome Measures: Comparing of objective sequelae and post-treatment subjective symptoms in three groups of erythema migrans patients treated with Doxycycline: with no accompanying symptoms, with mild and with severe symptoms at the beginning.;   Comparison of subjective symptoms between erythema migrans patients treated with Doxycycline and control subjects without a history of Lyme borreliosis.
5 Recruiting Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer
Condition: Pain
Intervention: Drug: Doxycycline
Outcome Measures: palliative benefit;   changes to bone formation markers
6 Recruiting Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
Conditions: Non-ischemic Cardiomyopathy;   Systolic Heart Failure (NYHA II-III)
Interventions: Drug: Doxycycline;   Drug: placebo
Outcome Measure: Peak aerobic exercise capacity
7 Recruiting Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study
Conditions: Chronic Pelvic Pain Syndrome;   Bladder Pain Syndrome
Interventions: Drug: Doxycycline;   Drug: placebo
Outcome Measures: Change in the O'Leary-Sant IC symptom and problem index total score from baseline;   Changes of patient reported pain, urgency, frequency, functional bladder capacity documented in 72-hour pain and bladder diary, completed during the 3 days before the particular follow-up visit.;   Changes in sexual function assessed by the Female Sexual Function Index (FSFI) at the time of the particular follow-up visit
8 Unknown  Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate
Condition: Mucositis
Intervention: Drug: Doxycycline hyclate
Outcome Measures: Complete response;   Partial resolution of oral lesions, incidence of infections and mortality.
9 Unknown  Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Inflammation;   Pulmonary Emphysema
Interventions: Drug: Doxycycline;   Drug: Placebo
Outcome Measures: myeloperoxidase in induced sputum;   MMP-8, MMP-9, IL-6 levels and differential cell counts in induced sputum.;   Lung function (FEV1);   Symptom scores
10 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
Outcome Measures: Overall treatment response;   • Health related quality of life questionnaires (GO-QoL);   • Safety and tolerability as assessed by adverse events, vital signs;   • Quantitative changes of rectus diameter measured by MRI scan;   Relapse
11 Recruiting Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome
Conditions: Polycystic Ovarian Syndrome (PCOS);   Irregular Menstrual Cycles;   Androgen Excess
Interventions: Drug: Doxycycline;   Drug: Sugar Pill
Outcome Measures: Assess the effectiveness of daily Doxycycline use in the primary outcome of reduction of serum testosterone and in women with PCOS during and beyond the treatment course.;   Assess the effectiveness of daily Doxycycline use in the secondary outcome of restoring ovulation in women with PCOS during and beyond the treatment course.
12 Unknown  Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
Condition: Suspected Early Lyme Neuroborreliosis
Interventions: Drug: Doxycycline;   Drug: ceftriaxone
Outcome Measure: Objective sequelae and post-treatment subjective symptoms in patients treated for suspected early Lyme neuroborreliosis with normal CSF cell count with Doxycycline or ceftriaxone for 14 days.
13 Recruiting Doxycycline, Temozolomide and Ipilimumab in Melanoma
Condition: Melanoma
Interventions: Drug: Doxycycline;   Drug: Ipilimumab;   Drug: Temozolomide
Outcome Measure: Overall Response Rate
14 Unknown  Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs
Condition: Breakthrough Bleeding
Intervention: Drug: Doxycycline
Outcome Measures: Determine the effect of combined oral contraceptives on endometrial MMP expression.;   Determine the effect of sub-antimicrobial Doxycycline on MMP expression and activity in continuous oral contraceptive users.
15 Recruiting Antibiotic Treatment of Multiple Erythema Migrans
Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone;   Drug: Doxycycline;   Other: erythema migrans patients treated with Doxycycline
Outcome Measures: Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, dizziness, or irritability in patients treated for multiple erythema migrans with ceftriaxone or Doxycycline for 15 days.;   Comparison of subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, or irritability between patients treated with antibiotic for multiple erythema migrans and control subjects without a history of Lyme borreliosis.;   Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, dizziness, or irritability in patients with solitary versus multiple erythema migrans after antibiotic treatment.
16 Recruiting A Phase II Study of Doxycycline in Relapsed NHL
Conditions: Adult Diffuse Large B-Cell Lymphoma;   Mantle Cell Lymphoma Recurrent;   Lymphoma, Follicular;   Marginal Zone B-Cell Lymphoma;   Malignant Lymphoma - Lymphoplasmacytic;   Waldenstrom Macroglobulinemia;   Small Lymphocytic Lymphoma;   Chronic Lymphocytic Leukemia (CLL);   T-Cell Lymphoma
Intervention: Drug: Doxycycline
Outcome Measures: Overall response rate;   Progression free survival
17 Unknown  The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Conditions: Acne;   Inflammation
Intervention: Drug: Doxycycline
Outcome Measure:
18 Recruiting Doxycycline for COPD in HIV-Infected Patients
Conditions: HIV;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
Intervention: Drug: Doxycycline
Outcome Measures: Safety and tolerability;   Larger phase II clinical trial
19 Recruiting Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
Conditions: Amyloidosis; Heart (Manifestation);   Senile Cardiac Amyloidosis
Intervention: Drug: Tauroursodeoxycholic Acid and Doxycycline
Outcome Measures: The rate of progression of transthyretin cardiac amyloidosis, as measured by changes in strain echocardiography, in a group of patients taking a combination of Doxycycline and TUDCA.;   Number of patients with adverse events to the medications over the period of therapy (18 months);   To evaluate general and health related quality of life (QoL) in SSA and ATTR subjects.
20 Recruiting Management of Etonogestrel Subdermal Implant-related Bleeding
Condition: ESI-related Bleeding
Interventions: Drug: Doxycycline;   Drug: Placebo
Outcome Measures: Efficacy and safety of Doxycycline compared to placebo for unacceptable bleeding;   Patient Satisfaction;   Method Continuation rate